16 completed, 6 recruiting, 4 not yet recruiting, 4 unknown. 23 Not applicable, 9 Phase 2, 6 Phase 3, 2 Phase 4, 1 Phase 1.
Follow KCRI: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Triton 1.5 Robotic System for Diagnostic Colonoscopy in the Middle East Diagnostic Test: Diagnostic Colonoscopy - Colonoscopy, Colorectal Cancer Screening | Not applicable | Not yet recruiting | Neptune Medical | 30 | 2026-10-12 | 2026-09-23 |
| BrainProtect-guided, Real-time Cerebral Autoregulation Monitoring and Protection of Brain During Cardiac Surgery With Cardiopulmonary Bypass Requiring Heart-lung Machine BrainProtect System, Standard perioperative management - Cerebral Autoregulation Impairment, Postoperative Cognitive Dysfunction | Not applicable | Not yet recruiting | Scienceforbrain, UAB | 304 | 2026-09-30 | 2026-10-14 |
| Triton 1.5 Robotic System for Diagnostic Colonoscopy Diagnostic Test: Diagnostic Colonoscopy - Colonoscopy, Colorectal Cancer Screening | Not applicable | Active not recruiting | Neptune Medical | 40 | 2026-08-24 | 2026-09-17 |
| Vibrato Aspiration System - Simple, Intuitive Approach to Clot Removal in Acute Pulmonary Embolism - a Safety & Feasibility Study Mechanical Thrombectomy - Pulmonary Embolism Acute | Not applicable | Recruiting | Vicora, Inc. | 10 | 2026-08-21 | 2026-08-25 |
| Safety and Efficacy Evaluation of ArtiFix® Sealant Graft in Subjects Requiring Dural Repair Following Neurosurgery ArtiFix® is a surgical dural sealant graft intended to close dural defects following cranial and spine surgeries. - Cerebrospinal Fluid Leak, Dural Tear | Not applicable | Not yet recruiting | Nurami Medical Ltd | 20 | 2025-11-01 | 2025-08-14 |
| Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass ATEV with ESS - Coronary Artery Disease, Multi Vessel Coronary Artery Disease | Not applicable | Enrolling by invitation | Vascudyne, Inc. | 20 | 2025-08-28 | 2026-07-29 |
| FlexiOss® - Efficacy, Safety and Long-term (Radiological and Clinical) Outcomes During Comprehensive Care Continuum of Implanted Biocomposite for Bone Regeneration. FlexiOss®, Allogenic human bone grafting - Bone Defect | Not applicable | Recruiting | Medical Inventi S.A. | 80 | 2025-05-29 | 2026-02-12 |
| Robotic Colonoscopy Using the Triton 4.0 System in Adults for Screening, Surveillance, and Diagnosis of Lower Gastrointestinal Conditions Diagnostic Colonoscopy - Colonoscopy, Colorectal Cancer Screening | Not applicable | Not yet recruiting | Neptune Medical | 50 | 2025-04-14 | 2025-04-20 |
| STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions Paclitaxel Coated Peripheral Angioplasty Balloon Catheter - Popliteal Artery Stenosis Above the Knee, Peripheral Artery Disease | Not applicable | Recruiting | Balton Sp.zo.o. | 120 | 2024-09-15 | 2024-12-16 |
| SENTANTE: Fully Robotic Peripheral Endovascular Interventions Endovascular intervention using the SENTANTE endovascular robotic system - Any Disease Which Requires Peripheral Endovascular Intervention | Not applicable | Completed | Inovatyvi Medicina UAB | 10 | 2024-07-19 | 2025-05-16 |
| Evaluation of the Performance of the Cardiolens® Platform, Which Utilizes a Non-Invasive Combined Anatomical and Functional CCTA-based Assessment in Patients With Suspected CCS CCTA (Coronary Computed Tomography Angiography), ICA (Invasive Coronary Angiography), FFR (Fractional Flow Reserve) - Chronic Coronary Syndrome | Completed | Hemolens Diagnostics Sp. z o.o. | 150 | 2023-10-18 | 2026-03-18 | |
| Safety and Preliminary Performance of Xtrac O.S. System for Lead Extraction. lead extraction (Xtrac O.S. system) - Bradycardia | Not applicable | Unknown | Xtrac O.S. | 10 | 2023-08-27 | 2024-08-13 |
| Permanent Pacemaker Implantation or Cardioneuroablation in Sinus Node Dysfunction Permament pacemaker implantation, Cardioneuroablation - Sinus Node Dysfunction | Not applicable | Unknown | Stec, Sebastian, MD, PhD, FESC | 60 | 2022-06-01 | 2023-03-07 |
| Safety and Performance Study of the Optimum Transcatheter Aortic Valve Transcatheter Aortic Valve (TAV) Implantation With The Optimum TAV System - Severe Aortic Stenosis | Not applicable | Recruiting | Thubrikar Aortic Valve, Inc. | 5 | 2022-05-18 | 2022-09-21 |
| Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases MesoCellA-Ortho administration, HA administration - Osteoarthritis of Knee | Phase 1 / Phase 2 | Completed | Jagiellonian University | 192 | 2022-01-05 | 2024-03-21 |
| Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes Cladribine - Acute Myeloid Leukemia Myelodysplastic Syndromes | Phase 2 | Active not recruiting | Maria Sklodowska-Curie National Research Institute of Oncology | 40 | 2021-10-07 | 2025-04-24 |
| Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL" Obinutuzumab, Rituximab - CD20-positive Acute Lymphoblastic Leukemia | Phase 2 | Terminated | Maria Sklodowska-Curie National Research Institute of Oncology | 49 | 2021-10-05 | 2026-10-15 |
| Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment Opdivo - Nasopharyngeal Cancer | Phase 2 | Recruiting | Maria Sklodowska-Curie National Research Institute of Oncology | 32 | 2021-08-26 | 2026-10-20 |
| Evaluation of Safety and Performance of the Omega™ LAA (Left Atrial Appendage) Occluder and Omega™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk Omega™LAA Occluder implantation - Non-Valvular Atrial Fibrillation | Not applicable | Active not recruiting | Eclipse Medical Ltd. | 200 | 2020-11-17 | 2025-12-03 |
| Clinical Investigation of Safety and Performance of a Medical Device (ClearPlasma) for the Treatment of Patients With Acute Upper Gastrointestinal Hemorrhage. Plasma treated with ClearPlasma (Extra-corporeal plasma filtration device), Regular fresh-frozen plasma (not treated) - Acute Upper Gastrointestinal Hemorrhage, Acute Upper Gastrointestinal Bleeding | Not applicable | Completed | PlasFree Ltd. | 53 | 2020-10-24 | 2022-11-15 |
Showing 20 of 37. Sign in to see all of them.
Angina, Unstable (3) · Colorectal Neoplasms (3) · Peripheral Arterial Disease (3) · Angina Pectoris (2) · Angina, Stable (2) · Bradycardia (2) · Coronary Artery Disease (2) · Heart Failure (2) · Myocardial Infarction (2) · ST Elevation Myocardial Infarction (2) · Aortic Valve Stenosis (1) · Arterial Occlusive Diseases (1) · Atherosclerosis (1) · Atrial Fibrillation (1) · Atrial Flutter (1)
Cardiovascular Agents (1) · Cladribine (1) · Clopidogrel (1) · Drug Implants (1) · Nivolumab (1) · Rituximab (1) · Transcatheter Aortic Valve Replacement (1) · obinutuzumab (1)
Poland (26) · Germany (3) · Italy (3) · Austria (2) · Czechia (2) · Israel (2) · Spain (2) · Australia (1) · Canada (1) · Denmark (1) · Ireland (1) · Kazakhstan (1) · Latvia (1) · Lithuania (1) · Russia (1)
Dariusz Dudek, MD, PhD (2) · Jacek Legutko, MD, PhD (2) · Amadeusz Skiba, PhD (1) · Carlo Gazzola, B. Sc. (1) · Christian Senft, Prof. Dr. (1) · Dainis Krievins, Prof PhD MD (1) · Dariusz Dudek, Prof. (1) · Florim Cuculi, MD, PhD (1) · Francesco Franceschi, MD (1) · Grzegorz Oszkinis, Prof. (1) · Horst Sievert, profesor (1) · Jason Samarasena, MD (1) · Joseph Milbaum (1)
PMID 26670056, PMID 28376837, PMID 30052304, PMID 32076567, PMID 39202618, PMID 40820307, PMID 40928505, PMID 41663151, PMID 42532411
2019 (1)